{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T13:07:10Z","timestamp":1771074430126,"version":"3.50.1"},"publisher-location":"New York, NY","reference-count":17,"publisher":"Springer US","isbn-type":[{"value":"9781071636282","type":"print"},{"value":"9781071636299","type":"electronic"}],"license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024]]},"DOI":"10.1007\/978-1-0716-3629-9_5","type":"book-chapter","created":{"date-parts":[[2024,3,21]],"date-time":"2024-03-21T07:01:51Z","timestamp":1711004511000},"page":"93-104","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Assays for the Screening and Characterization of Tau Aggregation Inhibitors"],"prefix":"10.1007","author":[{"given":"David","family":"Horsley","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janet E.","family":"Rickard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Vorley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matilda F.","family":"Leeper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claude M.","family":"Wischik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2250-3920","authenticated-orcid":false,"given":"Charles R.","family":"Harrington","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,3,22]]},"reference":[{"key":"5_CR1","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/S0165-0173(00)00019-9","volume":"33","author":"L Bu\u00e9e","year":"2000","unstructured":"Bu\u00e9e L, Bussi\u00e8re T, Bu\u00e9e-Scherrer V et al (2000) Tau protein isoforms, phosphorylation and role in neurodegenerative disorders. Brain Res Rev 33:95\u2013130","journal-title":"Brain Res Rev"},{"key":"5_CR2","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1002\/j.1460-2075.1993.tb05665.x","volume":"12","author":"M Novak","year":"1993","unstructured":"Novak M, Kabat J, Wischik CM (1993) Molecular characterization of the minimal protease resistant tau unit of the Alzheimer\u2019s disease paired helical filament. EMBO J 12:365\u2013370","journal-title":"EMBO J"},{"key":"5_CR3","doi-asserted-by":"publisher","first-page":"4506","DOI":"10.1073\/pnas.85.12.4506","volume":"85","author":"CM Wischik","year":"1988","unstructured":"Wischik CM, Novak M, Th\u00f8gersen HC et al (1988) Isolation of a fragment of tau derived from the core of the paired helical filament of Alzheimer\u2019s disease. Proc Natl Acad Sci U S A 85:4506\u20134510","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5_CR4","doi-asserted-by":"crossref","unstructured":"Mukaetova-Ladinska EB, Garcia-Sierra F, Hurt J et al (2000) Staging of cytoskeletal and \u03b2-amyloid changes in human isocortex reveals biphasic synaptic protein response during progression of Alzheimer\u2019s disease. Am J Pathol 157:623\u2013636","DOI":"10.1016\/S0002-9440(10)64573-7"},{"key":"5_CR5","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1212\/WNL.42.3.631","volume":"42","author":"PW Arriagada","year":"1992","unstructured":"Arriagada PW, Growdon JH, Hedley-White ET, Hyman BT (1992) Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer\u2019s disease. Neurology 42:631\u2013639","journal-title":"Neurology"},{"key":"5_CR6","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/0022-510X(82)90155-1","volume":"56","author":"GK Wilcock","year":"1982","unstructured":"Wilcock GK, Esiri MM (1982) Plaques, tangles and dementia: a quantitative study. J Neurol Sci 56:343\u2013356","journal-title":"J Neurol Sci"},{"key":"5_CR7","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1016\/j.neuron.2013.07.037","volume":"79","author":"M Maruyama","year":"2013","unstructured":"Maruyama M, Shimada H, Suhara T et al (2013) Imaging of tau pathology in a tauopathy mouse model and in Alzheimer patients compared to normal controls. Neuron 79:1094\u20131108","journal-title":"Neuron"},{"key":"5_CR8","doi-asserted-by":"publisher","first-page":"1762","DOI":"10.1093\/brain\/awu064","volume":"137","author":"N Okamura","year":"2014","unstructured":"Okamura N, Furumoto S, Fodero-Tavoletti MT et al (2014) Non-invasive assessment of Alzheimer\u2019s disease neurofibrillary pathology using F-18-THK5105 PET. Brain 137:1762\u20131771","journal-title":"Brain"},{"key":"5_CR9","doi-asserted-by":"publisher","first-page":"11213","DOI":"10.1073\/pnas.93.20.11213","volume":"93","author":"CM Wischik","year":"1996","unstructured":"Wischik CM, Edwards PC, Lai RYK et al (1996) Selective inhibition of Alzheimer disease-like tau aggregation by phenothiazines. Proc Natl Acad Sci U S A 93:11213\u201311218","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5_CR10","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.3233\/JAD-170727","volume":"62","author":"CM Wischik","year":"2018","unstructured":"Wischik CM, Schelter BO, Wischik DJ et al (2018) Modeling prion-like processing of tau protein in Alzheimer\u2019s disease for pharmaceutical development. J Alzheimers Dis 62:1287\u20131303","journal-title":"J Alzheimers Dis"},{"key":"5_CR11","doi-asserted-by":"publisher","first-page":"4135","DOI":"10.1021\/jm3017317","volume":"56","author":"B Bulic","year":"2013","unstructured":"Bulic B, Pickhardt M, Mandelkow E (2013) Progress and developments in tau aggregation inhibitors for Alzheimer disease. J Med Chem 56:4135\u20134155","journal-title":"J Med Chem"},{"key":"5_CR12","doi-asserted-by":"publisher","first-page":"7614","DOI":"10.1074\/jbc.M408714200","volume":"280","author":"S Taniguchi","year":"2005","unstructured":"Taniguchi S, Suzuki N, Masuda M et al (2005) Inhibition of heparin-induced tau filament formation by phenothiazines, polyphenols, and porphyrins. J Biol Chem 280:7614\u20137623","journal-title":"J Biol Chem"},{"key":"5_CR13","doi-asserted-by":"publisher","first-page":"10862","DOI":"10.1074\/jbc.M114.616029","volume":"290","author":"CR Harrington","year":"2015","unstructured":"Harrington CR, Storey JMD, Clunas S et al (2015) Cellular models of aggregation-dependent template-directed proteolysis to characterize tau aggregation inhibitors for treatment of Alzheimer\u2019s disease. J Biol Chem 290:10862\u201310875","journal-title":"J Biol Chem"},{"key":"5_CR14","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1097\/FBP.0000000000000133","volume":"26","author":"V Melis","year":"2015","unstructured":"Melis V, Magbagbeolu M, Rickard JE et al (2015) Effects of oxidized and reduced forms of methylthioninium in two transgenic mouse tauopathy models. Behav Pharmacol 26:353\u2013368","journal-title":"Behav Pharmacol"},{"key":"5_CR15","first-page":"245","volume-title":"Brain microtubule associated proteins: modifications in disease","author":"R Brandt","year":"1997","unstructured":"Brandt R, Kempf M, Lee G (1997) Expression and purification of tau for in vitro studies. In: Avila J, Brandt R, Kosik KS (eds) Brain microtubule associated proteins: modifications in disease. Harwood Academic Publishers, Amsterdam, pp 245\u2013257"},{"key":"5_CR16","doi-asserted-by":"publisher","first-page":"5837","DOI":"10.1073\/pnas.88.13.5837","volume":"88","author":"M Novak","year":"1991","unstructured":"Novak M, Jakes R, Edwards PC et al (1991) Difference between the tau protein of Alzheimer paired helical filament core and normal tau revealed by epitope analysis of mAbs 423 and 7.51. Proc Natl Acad Sci U S A 88:5837\u20135841","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5_CR17","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/0022-1759(90)90388-C","volume":"134","author":"CR Harrington","year":"1990","unstructured":"Harrington CR, Edwards PC, Wischik CM (1990) Competitive ELISA for measurement of tau proteins in Alzheimer\u2019s disease. J Immunol Meth 134:261\u2013271","journal-title":"J Immunol Meth"}],"container-title":["Methods in Molecular Biology","Tau Protein"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-3629-9_5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,21]],"date-time":"2024-03-21T07:02:14Z","timestamp":1711004534000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-3629-9_5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"ISBN":["9781071636282","9781071636299"],"references-count":17,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-3629-9_5","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024]]},"assertion":[{"value":"22 March 2024","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}